Journal
AMERICAN JOURNAL OF INDUSTRIAL MEDICINE
Volume 56, Issue 3, Pages 300-307Publisher
WILEY
DOI: 10.1002/ajim.22125
Keywords
indium; indium-tin oxide; interstitial lung disease; occupational illness; surveillance
Categories
Funding
- National Institute for Occupational Safety and Health, Centers for Diseases Control and Prevention
Ask authors/readers for more resources
Background We evaluated the effectiveness of workplace changes to prevent indium lung disease, using 20022010 surveillance data collected by an indium-tin oxide production facility. Methods We assessed pulmonary function using lower limits of normal. Blood indium concentration and personal air sampling data were used to estimate exposure. Results Abnormalities were uncommon at hire. After hire, prevalence of spirometric restriction was 31% (n=14/45), about fourfold higher than expected. Excessive decline in FEV1 was elevated at 29% (n=12/41). Half (n=21/42) had blood indium 5 mu g/l. More recent hires had fewer abnormalities. There was a suggestion that abnormalities were more common among workers with blood indium 5 mu g/l, but otherwise an exposure-response relationship was not evident. Peak dust concentrations were obscured by time averaging. Conclusions Evolving lung function abnormalities consistent with subclinical indium lung disease appeared common and merit systematic investigation. Traditional measures of exposure and response were not illustrative, suggesting fresh approaches will be needed. Workplace changes seemed to have had a positive though incomplete impact; novel preventive interventions are warranted. Am. J. Ind. Med. 56:300307, 2013. (c) 2012 Wiley Periodicals, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available